Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.66 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | CCR3 | P51677 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8108965 | 1.00 | SLC6A3 (0.66) | SLC6A3SIGMAR1HTR1ADRD2ACHE | |
| Hydrochloric Acid SCHEMBL486705 | 0.98 | SLC6A3 (0.63) | SLC6A3SIGMAR1HTR1ADRD2ACHE | |
| Iodide SCHEMBL195620 | 0.98 | SLC6A3 (0.63) | SLC6A3SIGMAR1HTR1ADRD2ACHE | |
| Hydrochloric Acid SCHEMBL7810971 | 0.92 | SLC6A3 (0.66) | SLC6A3SIGMAR1HTR1ADRD2NPC1 | |
| SCHEMBL3959376 | 0.89 | SIGMAR1 (0.72) | SIGMAR1CCR3 | |
| SCHEMBL21047654 | 0.89 | SLC6A3 (0.56) | SLC6A3SIGMAR1HTR1ADRD2ACHE | |
| SCHEMBL6705256 | 0.87 | SIGMAR1 (0.67) | SIGMAR1CCR3MEN1KMT2A | |
| SCHEMBL5612374 | 0.86 | SIGMAR1 (0.70) | SIGMAR1CCR3MEN1KMT2A | |
| SCHEMBL14407778 | 0.83 | SLC6A3 (0.83) | SLC6A3SIGMAR1HTR1ADRD2ACHE | |
| SCHEMBL6056974 | 0.83 | SLC6A3 (0.83) | SLC6A3SIGMAR1HTR1ADRD2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12340996-B2 | Method for rapid on-site detection of fentanyl analogs using a miniature mass spectrometer | CHINESE ACADEMY OF INSPECTION AND QUARANTINE (CN) | 2025-06-24 | — | — | US | claimed |
| US-20250189547-A1 | SURFACE-ENHANCED RAMAN NANOPARTICLE AND DETECTION METHOD FOR FENTANYLS | Shenzhen Customs Industrial Products Testing Technology Center (CN) | 2025-06-12 | — | — | US | claimed |
| CN-117664949-A | Detection method of surface-enhanced Raman nano particles and fentanyl substances | 深圳海关工业品检测技术中心 | 2024-03-08 | — | — | CN | claimed |
| CN-117551203-A | Preparation process of fentanyl monoclonal antibody | 浙江工商大学 | 2024-02-13 | — | — | CN | claimed |
| CN-111257574-B | Fluorescent immunity rapid detection card for rapid screening of fentanyl substances and preparation method | 中检国研(北京)科技有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-116519657-A | Surface-enhanced Raman spectrum substrate and preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2023-08-01 | — | — | CN | claimed |
| CN-113376277-B | High-resolution mass spectrometry detection method for fentanyl drugs in health care products | 西安海关技术中心 | 2023-03-17 | — | — | CN | claimed |
| US-20230015987-A1 | METHOD FOR RAPID ON-SITE DETECTION OF FENTANYL ANALOGS USING A MINIATURE MASS SPECTROMETER | CHINESE ACADEMY OF INSPECTION AND QUARANTINE (CN) | 2023-01-19 | — | — | US | claimed |
| CN-113375997-B | Method and product for detecting fentanyl compound | 赛默飞世尔（上海）仪器有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-113375997-A | Method and product for detecting fentanyl compound | 赛默飞世尔（上海）仪器有限公司 | 2021-09-10 | — | — | CN | claimed |
| US-8710118-B2 | Nano-pigment inkjet ink composition that has a low odor and is environmentally-friendly | JETBEST CORPORATION (TW) | 2014-04-29 | — | — | US | claimed |
| US-20130190421-A1 | LOW ODOR ENVIRONMENTALLY-FRIENDLY NANO-PIGMENT INKJET INK COMPOSITION | JETBEST CORPORATION (TW) | 2013-07-25 | — | — | US | claimed |
| EP-2617779-A1 | Low odor environmentally-friendly nano-pigment inkjet ink composition | JETBEST Corporation (TW) | 2013-07-24 | — | — | EP | claimed |
| EP-1406623-B1 | SUBSTITUTED 1-PHENETHYLPIPERIDINE COMPOUNDS USED AS INTER ALIA ANALGESICS | GRUENENTHAL GMBH (DE) | 2007-12-12 | — | — | EP | claimed |
| US-20060100438-A1 | Process of making fentanyl intermediates | BOEHRINGER INGELHEIM CHEMICALS, INC. (US) | 2006-05-11 | — | — | US | claimed |
| US-20040171640-A1 | Substituted 1-phenethylpiperidine compounds used as inter alia analgesics | GRUNENTHAL GMBH (DE) | 2004-09-02 | — | — | US | claimed |
| EP-1406623-A1 | SUBSTITUTED 1-PHENETHYLPIPERIDINE COMPOUNDS USED AS INTER ALIA ANALGESICS | Grünenthal GmbH (DE) | 2004-04-14 | — | — | EP | claimed |
| WO-2003004026-A1 | SUBSTITUTED 1-PHENETHYLPIPERIDINE COMPOUNDS USED AS INTER ALIA ANALGESICS | Grünenthal GmbH (DE) | 2003-01-16 | — | — | WO | claimed |
| US-5106983-A | Process of making carfentanil and related analgesics | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1992-04-21 | — | — | US | claimed |
| EP-0394039-A1 | A method for preparing 4-Alkoxyalkyl-4-aminophenylpiperidines and derivatives thereof | BOC, INC. (US) | 1990-10-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171640-A1 | Substituted 1-phenethylpiperidine compounds used as inter alia analgesics | PNMT, OPRK1, OPRM1 | SLC6A3 565/4885SIGMAR1 30/4885HTR1A 11/4885 |
| US-20060100438-A1 | Process of making fentanyl intermediates | OPRK1, OPRD1, OPRM1 | SLC6A3 987/4885SIGMAR1 45/4885HTR1A 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.